The Chemours Company (NYSE:CC) Shares Bought by Raymond James Financial Services Advisors Inc.

Raymond James Financial Services Advisors Inc. raised its stake in The Chemours Company (NYSE:CC) by 12.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 29,431 shares of the specialty chemicals company’s stock after acquiring an additional 3,206 shares during the period. Raymond James Financial Services Advisors Inc.’s holdings in Chemours were worth $928,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently bought and sold shares of CC. Legacy Financial Group LLC bought a new position in shares of Chemours in the third quarter valued at $29,000. Atlas Capital Advisors LLC acquired a new position in Chemours during the 2nd quarter worth $52,000. Anchor Investment Management LLC acquired a new position in Chemours during the 4th quarter worth $56,000. Steward Partners Investment Advisory LLC lifted its position in Chemours by 117.2% during the 1st quarter. Steward Partners Investment Advisory LLC now owns 2,098 shares of the specialty chemicals company’s stock worth $63,000 after acquiring an additional 1,132 shares during the last quarter. Finally, IFP Advisors Inc lifted its position in Chemours by 39.0% during the 3rd quarter. IFP Advisors Inc now owns 2,232 shares of the specialty chemicals company’s stock worth $63,000 after acquiring an additional 626 shares during the last quarter. 76.26% of the stock is currently owned by institutional investors and hedge funds.

Chemours Stock Performance

NYSE:CC opened at $26.03 on Tuesday. The Chemours Company has a 12-month low of $15.10 and a 12-month high of $39.05. The company has a quick ratio of 1.00, a current ratio of 1.54 and a debt-to-equity ratio of 5.40. The firm has a market capitalization of $3.87 billion, a PE ratio of -16.79 and a beta of 2.00. The firm has a 50-day moving average price of $27.20 and a 200 day moving average price of $27.83.

Chemours Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, March 15th. Investors of record on Monday, February 26th were given a $0.25 dividend. This represents a $1.00 annualized dividend and a yield of 3.84%. The ex-dividend date of this dividend was Friday, February 23rd. Chemours’s dividend payout ratio (DPR) is presently -64.52%.

Analyst Ratings Changes

CC has been the subject of a number of research analyst reports. UBS Group boosted their target price on shares of Chemours from $21.00 to $28.00 and gave the stock a “neutral” rating in a research report on Tuesday, April 2nd. Barclays cut their price objective on shares of Chemours from $32.00 to $30.00 and set an “equal weight” rating for the company in a research report on Tuesday, April 2nd. Finally, BMO Capital Markets raised shares of Chemours from an “underperform” rating to an “outperform” rating and upped their price objective for the company from $19.00 to $34.00 in a research report on Tuesday, April 9th. Seven investment analysts have rated the stock with a hold rating and two have given a buy rating to the company. According to data from MarketBeat.com, Chemours currently has an average rating of “Hold” and a consensus target price of $30.89.

Chemours Profile

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.